Madrigal Pharmaceuticals, Inc. MDGL Geographic — Operating lease, liability
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
In April 2025, the Company entered into an operating lease for additional office space in West Conshohocken, Pennsylvania. The lease commenced in May 2025 and resulted in a $4.0 million right-of-use asset and lease liability. In March 2026, the Company entered into an amendment to this lease, which modified the lease term and payment schedule. As a result, the right-of-use asset and lease liability balances were remeasured to $4.0 million and $4.6 million, respectively.
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s geographic — operating lease, liability?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported geographic — operating lease, liability of $4.6M in Q2 2026.
- What does geographic — operating lease, liability mean?
- This metric represents the present value of future lease payments for the company's facilities in West Conshohocken, Pennsylvania, recognized as a liability on the balance sheet. It captures the total financial obligation associated with the company's primary office or research site lease agreements. Monitoring this liability provides insight into the company's fixed contractual cash outflows and long-term financial leverage related to its physical infrastructure.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s geographic — operating lease, liability.
Connect your AI assistant and compare it to peers, right in your chat.
